Back
Larimar Therapeutics 10K Form
Buy
56
LRMR
Larimar Therapeutics
Last Price:
7.54
Seasonality Move:
27.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LRMR News And Ratings
See the #1 stock for the next 7 days that we like better than LRMR
LRMR Financial Statistics
Sales & Book Value
Annual Sales: | -- |
---|---|
Cash Flow: | $-14.26M |
Price / Cash Flow: | 0 |
Annual Sales: | $3.31 |
Price / Book: | 2.34 |
Profitability
EPS (TTM): | -1.11000 |
---|---|
Net Income (TTM): | $-58.34M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Larimar Therapeutics Earnings Forecast
Key Larimar Therapeutics Financial Ratios
- Per Share Earnings over the last 5 years have been positive in 3 years.
Larimar Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | LRMR |
CUSIP: | 517125 |
Website: | larimartx.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
LRMR Technical Analysis vs Fundamental Analysis
Buy
56
Larimar Therapeutics (LRMR)
is a Buy
Is Larimar Therapeutics a Buy or a Sell?
-
Larimar Therapeutics stock is rated a Buy
The current Larimar Therapeutics [LRMR] share price is $7.74. The Score for LRMR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.